http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020360492-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-24069
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
filingDate 2020-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56672bb9941c3929e771662f2e0fc4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdad4155a04b52d0337520f08a0ce8c2
publicationDate 2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020360492-A1
titleOfInvention Injection paradigm for administration of botulinum toxins
abstract Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
priorityDate 2015-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013224180-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688096

Total number of triples: 24.